PharmAgents introduces a framework where LLM-powered agents collaborate to accelerate small molecule drug discovery and development.

• Creates a virtual pharmaceutical company with specialized AI agents mimicking roles throughout the drug development pipeline
• Enables multidisciplinary collaboration between AI agents to overcome traditional drug discovery bottlenecks
• Demonstrates potential to make drug development more efficient and cost-effective

This research represents a significant advancement in medical AI, offering pharmaceutical companies a way to augment traditional drug discovery methods, potentially reducing time-to-market for new therapies and expanding treatment options for patients.

PharmAgents: Building a Virtual Pharma with Large Language Model Agents